CD8A and neoplasm: The different susceptibility of fresh CD8+ and Vδ2 T cells-, and the expanded Vγ2Vδ2 T cells-modulated the killing activities of tumor cells induced by Y111 may be attributed to the various action mechanisms of the TCR activation by these cells (43, 44).